These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2345633)

  • 1. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
    Müzes G; Deák G; Láng I; Nékám K; Niederland V; Fehér J
    Orv Hetil; 1990 Apr; 131(16):863-6. PubMed ID: 2345633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
    Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
    Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
    Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the natural bioflavonoid antioxidant silymarin on superoxide dismutase (SOD) activity and expression in vitro.
    Láng I; Deák G; Müzes G; Prónai L; Fehér J
    Biotechnol Ther; 1993; 4(3-4):263-70. PubMed ID: 8292974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effect of free radical scavenger hepatoprotective agents on superoxide dismutase (SOD) activity in patients.
    Fehér J; Láng I; Nékám K; Gergely P; Mũzes G
    Tokai J Exp Clin Med; 1990 May; 15(2-3):129-34. PubMed ID: 2130521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme.
    Müzes G; Deák G; Láng I; Nékám K; Gergely P; Fehér J
    Acta Physiol Hung; 1991; 78(1):3-9. PubMed ID: 1763650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of free radical scavengers on superoxide dismutase (SOD) enzyme in patients with alcoholic cirrhosis.
    Fehér J; Láng I; Nékám K; Müzes G; Deák G
    Acta Med Hung; 1988; 45(3-4):265-76. PubMed ID: 3249654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of silibinin (Legalon) on the the free radical scavenger mechanisms of human erythrocytes in vitro.
    Altorjay I; Dalmi L; Sári B; Imre S; Balla G
    Acta Physiol Hung; 1992; 80(1-4):375-80. PubMed ID: 1345204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free radicals in tissue damage in liver diseases and therapeutic approach.
    Fehér J; Láng I; Deák G; Cornides A; Nékám K; Gergely P
    Tokai J Exp Clin Med; 1986; 11 Suppl():121-34. PubMed ID: 3452238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of silibinin on the activity and expression of superoxide dismutase in lymphocytes from patients with chronic alcoholic liver disease.
    Fehér J; Láng I; Nékám K; Csomós G; Müzes G; Deák G
    Free Radic Res Commun; 1987; 3(6):373-7. PubMed ID: 3508451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of silymarin on erythrocyte haemolysate against benzo(a)pyrene and exogenous reactive oxygen species (H2O2) induced oxidative stress.
    Kiruthiga PV; Shafreen RB; Pandian SK; Arun S; Govindu S; Devi KP
    Chemosphere; 2007 Jul; 68(8):1511-8. PubMed ID: 17481694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients].
    Trinchet JC; Coste T; Lévy VG; Vivet F; Duchatelle V; Legendre C; Gotheil C; Beaugrand M
    Gastroenterol Clin Biol; 1989; 13(2):120-4. PubMed ID: 2707520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M; Moayedi B; Zakerinia M; Hamidi M; Karimi M; Maracy M; Amirghofran Z
    Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled study of the effect of silymarin on alcoholic liver disease].
    Bunout D; Hirsch S; Petermann M; de la Maza MP; Silva G; Kelly M; Ugarte G; Iturriaga H
    Rev Med Chil; 1992 Dec; 120(12):1370-5. PubMed ID: 1343377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats.
    Sathiavelu J; Senapathy GJ; Devaraj R; Namasivayam N
    J Pharm Pharmacol; 2009 Jun; 61(6):809-17. PubMed ID: 19505373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term treatment of type II hyperlipoproteinaemia with silymarin.
    Somogyi A; Ecsedi GG; Blázovics A; Miskolczi K; Gergely P; Fehér J
    Acta Med Hung; 1989; 46(4):289-95. PubMed ID: 2699920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotective and immunological effects of antioxidant drugs.
    Láng I; Nékám K; González-Cabello R; Mũzes G; Gergely P; Fehér J
    Tokai J Exp Clin Med; 1990 May; 15(2-3):123-7. PubMed ID: 1983370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-fatty liver effects of garlic oil on acute ethanol-exposed mice.
    Zeng T; Guo FF; Zhang CL; Zhao S; Dou DD; Gao XC; Xie KQ
    Chem Biol Interact; 2008 Nov; 176(2-3):234-42. PubMed ID: 18718457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoprotective and immunomodulatory effects of antioxidant therapy.
    Láng I; Deák G; Nékám K; Müzes G; González-Cabello R; Gergely P; Fehér J
    Acta Med Hung; 1988; 45(3-4):287-95. PubMed ID: 3074277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.